A detailed history of Coastal Bridge Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Coastal Bridge Advisors, LLC holds 9,737 shares of MRK stock, worth $965,715. This represents 0.31% of its overall portfolio holdings.

Number of Shares
9,737
Previous 9,716 0.22%
Holding current value
$965,715
Previous $1.2 Million 8.07%
% of portfolio
0.31%
Previous 0.34%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$111.15 - $128.97 $2,334 - $2,708
21 Added 0.22%
9,737 $1.11 Million
Q2 2024

Aug 15, 2024

SELL
$123.8 - $132.96 $170,844 - $183,484
-1,380 Reduced 12.44%
9,716 $1.2 Million
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $2,491 - $2,902
22 Added 0.2%
11,096 $1.46 Million
Q4 2023

Feb 15, 2024

BUY
$100.18 - $109.02 $2,404 - $2,616
24 Added 0.22%
11,074 $1.21 Million
Q3 2023

Nov 14, 2023

BUY
$102.95 - $114.33 $33,149 - $36,814
322 Added 3.0%
11,050 $1.14 Million
Q2 2023

Aug 16, 2023

BUY
$108.61 - $118.38 $20,961 - $22,847
193 Added 1.83%
10,728 $1.24 Million
Q1 2023

May 15, 2023

BUY
$102.94 - $114.86 $1,955 - $2,182
19 Added 0.18%
10,535 $1.12 Million
Q4 2022

Feb 08, 2023

BUY
$87.44 - $112.11 $2,186 - $2,802
25 Added 0.24%
10,516 $1.17 Million
Q3 2022

Nov 15, 2022

BUY
$84.53 - $94.96 $2,028 - $2,279
24 Added 0.23%
10,491 $903,000
Q2 2022

Nov 15, 2022

SELL
$83.49 - $94.64 $55,353 - $62,746
-663 Reduced 5.96%
10,467 $954,000
Q2 2022

Aug 05, 2022

BUY
$83.49 - $94.64 $57,524 - $65,206
689 Added 6.6%
11,130 $1.02 Million
Q1 2022

May 13, 2022

BUY
$73.51 - $82.4 $661 - $741
9 Added 0.09%
10,441 $857,000
Q4 2021

May 20, 2022

SELL
$72.28 - $90.54 $209,395 - $262,294
-2,897 Reduced 21.73%
10,432 $800,000
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $211,202 - $264,557
2,922 Added 28.08%
13,329 $1.02 Million
Q3 2021

May 20, 2022

SELL
$71.68 - $78.83 $202,854 - $223,088
-2,830 Reduced 21.38%
10,407 $782,000
Q3 2021

Nov 15, 2021

BUY
$71.68 - $78.83 $209,950 - $230,893
2,929 Added 28.41%
13,237 $994,000
Q2 2021

Aug 10, 2021

SELL
$70.31 - $77.77 $35,928 - $39,740
-511 Reduced 4.72%
10,308 $802,000
Q1 2021

May 17, 2021

BUY
$68.86 - $81.11 $169,671 - $199,855
2,464 Added 29.49%
10,819 $834,000
Q4 2020

Feb 16, 2021

BUY
$71.77 - $79.65 $7,751 - $8,602
108 Added 1.31%
8,355 $683,000
Q3 2020

Nov 13, 2020

BUY
$73.18 - $82.95 $1,683 - $1,907
23 Added 0.28%
8,247 $684,000
Q2 2020

Aug 11, 2020

BUY
$70.42 - $80.13 $1,690 - $1,923
24 Added 0.29%
8,224 $636,000
Q1 2020

May 14, 2020

BUY
$63.36 - $87.82 $11,848 - $16,422
187 Added 2.33%
8,200 $631,000
Q4 2019

Feb 13, 2020

SELL
$77.58 - $87.54 $4,189 - $4,727
-54 Reduced 0.67%
8,013 $729,000
Q3 2019

Nov 08, 2019

BUY
$76.08 - $82.93 $7,075 - $7,712
93 Added 1.17%
8,067 $679,000
Q2 2019

Aug 13, 2019

BUY
$69.84 - $81.59 $119,007 - $139,029
1,704 Added 27.18%
7,974 $669,000
Q2 2019

Aug 07, 2019

SELL
$69.84 - $81.59 $126,759 - $148,085
-1,815 Reduced 22.45%
6,270 $678,000
Q1 2019

May 08, 2019

BUY
$69.58 - $79.36 $36,112 - $41,187
519 Added 6.86%
8,085 $672,000
Q4 2018

Feb 08, 2019

BUY
$65.24 - $75.71 $1,239 - $1,438
19 Added 0.25%
7,566 $578,000
Q3 2018

Nov 08, 2018

SELL
$57.69 - $67.84 $4,095 - $4,816
-71 Reduced 0.93%
7,547 $535,000
Q2 2018

Aug 03, 2018

BUY
$50.83 - $59.72 $8,895 - $10,451
175 Added 2.35%
7,618 $462,000
Q1 2018

May 11, 2018

BUY
$50.96 - $59.23 $6,013 - $6,989
118 Added 1.61%
7,443 $405,000
Q4 2017

Feb 09, 2018

BUY
$51.62 - $61.64 $1,084 - $1,294
21 Added 0.29%
7,325 $412,000
Q3 2017

Nov 13, 2017

SELL
$58.67 - $63.13 $3,754 - $4,040
-64 Reduced 0.87%
7,304 $468,000
Q1 2017

Aug 14, 2017

BUY
N/A
7,368
7,368 $468,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Coastal Bridge Advisors, LLC Portfolio

Follow Coastal Bridge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coastal Bridge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Coastal Bridge Advisors, LLC with notifications on news.